STAAR Surgical Company (STAA)

US — Healthcare Sector
Peers: RMD  WST  ICUI  MMSI  MBOT  BDX  COO  HOLX  RGEN  HAE  NVST  ANGO  ATR 

Automate Your Wheel Strategy on STAA

With Tiblio's Option Bot, you can configure your own wheel strategy including STAA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol STAA
  • Rev/Share 5.6569
  • Book/Share 7.0925
  • PB 2.5844
  • Debt/Equity 0.1048
  • CurrentRatio 4.7764
  • ROIC -0.2

 

  • MktCap 907813413.0
  • FreeCF/Share -0.2772
  • PFCF -66.3606
  • PE -12.7248
  • Debt/Assets 0.0802
  • DivYield 0
  • ROE -0.1794

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 4
  • P/B Score 2
  • D/E Score 3

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation STAA Wells Fargo -- Equal Weight -- $17 April 21, 2025
Downgrade STAA BTIG Research Buy Neutral -- -- Feb. 12, 2025
Downgrade STAA Jefferies Buy Hold -- -- Feb. 12, 2025
Downgrade STAA Mizuho Outperform Neutral $45 $17 Feb. 12, 2025
Downgrade STAA William Blair Outperform Market Perform -- -- Feb. 12, 2025

News

STAAR Surgical Company Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - STAA
STAA
Published: February 18, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of STAAR Surgical Company ("STAAR Surgical Company") (NASDAQ:STAA) concerning possible violations of federal securities laws. Staar reported disappointing earnings for Q4 2024, blaming the results on weak demand in China and a drop in refractive procedures.

Read More
image for news STAAR Surgical Company Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - STAA
Levi & Korsinsky Investigates Possible Securities Fraud Violations by STAAR Surgical Company (STAA)
STAA
Published: February 17, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of STAAR Surgical Company ("STAAR Surgical Company") (NASDAQ:STAA) concerning possible violations of federal securities laws. Staar reported disappointing earnings for Q4 2024, blaming the results on weak demand in China and a drop in refractive procedures.

Read More
image for news Levi & Korsinsky Investigates Possible Securities Fraud Violations by STAAR Surgical Company (STAA)
STAAR Surgical Company Is Being Investigated For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
STAA
Published: February 17, 2025 by: Accesswire
Sentiment: Neutral

LOS ANGELES, CA / ACCESS Newswire / February 17, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of STAAR Surgical Company ("Staar" or "the Company") (NASDAQ:STAA) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Read More
image for news STAAR Surgical Company Is Being Investigated For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
Bronstein, Gewirtz & Grossman, LLC Encourages STAAR Surgical Company (STAA) Investors to Inquire about Securities Investigation
STAA
Published: February 17, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of STAAR Surgical Company ("STAAR" or "the Company") (NASDAQ:STAA). Investors who purchased STAAR securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/STAA.

Read More
image for news Bronstein, Gewirtz & Grossman, LLC Encourages STAAR Surgical Company (STAA) Investors to Inquire about Securities Investigation
The Schall Law Firm Invites Shareholders With Losses In STAAR Surgical Company To Join A Securities Fraud Investigation
STAA
Published: February 14, 2025 by: Accesswire
Sentiment: Neutral

LOS ANGELES, CA / ACCESS Newswire / February 14, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of STAAR Surgical Company ("Staar" or "the Company") (NASDAQ:STAA) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Read More
image for news The Schall Law Firm Invites Shareholders With Losses In STAAR Surgical Company To Join A Securities Fraud Investigation
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against STAAR Surgical Company (STAA) And Encourages Stockholders to Reach Out
STAA
Published: February 14, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / February 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of STAAR Surgical Company ("STAAR" or "the Company") (NASDAQ:STAA). Investors who purchased STAAR securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/STAA.

Read More
image for news Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against STAAR Surgical Company (STAA) And Encourages Stockholders to Reach Out
Lost Money on STAAR Surgical Company (STAA)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
STAA
Published: February 13, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of STAAR Surgical Company ("STAAR Surgical Company") (NASDAQ:STAA) concerning possible violations of federal securities laws. Staar reported disappointing earnings for Q4 2024, blaming the results on weak demand in China and a drop in refractive procedures.

Read More
image for news Lost Money on STAAR Surgical Company (STAA)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of STAAR Surgical Company. - STAA
STAA
Published: February 13, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / February 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:STAA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of STAAR Surgical Company. - STAA
STAAR Surgical Company Is Being Investigated For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
STAA
Published: February 13, 2025 by: Accesswire
Sentiment: Neutral

LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of STAAR Surgical Company ("Staar" or "the Company") (NASDAQ:STAA) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Read More
image for news STAAR Surgical Company Is Being Investigated For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
STAA Investors Have Opportunity to Join STAAR Surgical Company Fraud Investigation with the Schall Law Firm
STAA
Published: February 13, 2025 by: PRNewsWire
Sentiment: Neutral

LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of STAAR Surgical Company ("Staar" or "the Company") (NASDAQ: STAA) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Read More
image for news STAA Investors Have Opportunity to Join STAAR Surgical Company Fraud Investigation with the Schall Law Firm
STAAR Surgical Company (STAA) Q4 2024 Earnings Call Transcript
STAA
Published: February 13, 2025 by: Seeking Alpha
Sentiment: Neutral

STAAR Surgical Company (NASDAQ:STAA ) Q4 2024 Earnings Call Transcript February 11, 2025 5:00 PM ET Company Participants Brian Moore - VP, Investor Relations and Corporate Development Tom Frinzi - Chair of the Board, President and CEO Patrick Williams - CFO Conference Call Participants Iseult Mcmahon - BTIG Tom Stephan - Stifel Anthony Petrone - Mizuho Macauley Kilbane - William Blair Patrick Wood - Morgan Stanley Steve Lichtman - Oppenheimer Jim Sidoti - Sidoti & Co. Phillip Dantoin - Piper Sandler Jon Young - Canaccord David Saxon - Needham & Co. Mason Carrico - Stephens Operator Greetings and welcome to …

Read More
image for news STAAR Surgical Company (STAA) Q4 2024 Earnings Call Transcript
STAA Investors Have Opportunity to Join STAAR Surgical Company Fraud Investigation with the Schall Law Firm
STAA
Published: February 12, 2025 by: Business Wire
Sentiment: Neutral

LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of STAAR Surgical Company (“Staar” or “the Company”) (NASDAQ: STAA) for violations of the securities laws.

Read More
image for news STAA Investors Have Opportunity to Join STAAR Surgical Company Fraud Investigation with the Schall Law Firm

About STAAR Surgical Company (STAA)

  • IPO Date 1992-02-24
  • Website https://www.staar.com
  • Industry Medical - Instruments & Supplies
  • CEO Mr. Stephen C. Farrell CFA
  • Employees 1157

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.